Data Foundry

Drug recalls 2017

Ketorolac Tromethamine Injection — Class II drug recall D-1124-2017

Terminated recall by Amphastar Pharmaceuticals, Inc., reported 2017-09-06, distributed nationwide. Crystallization: Particulate matter (Ketorolac Calcium Salt) was observed from several lots of retained sample

Recall numberD-1124-2017
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmAmphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA, United States
Recall initiated2017-08-15
Classified2017-08-29
Reported by FDA2017-09-06
Terminated2019-01-14
DistributedNationwide (US)
Quantity637,810 vials
Reason classesspecification failure
NDC00548-9021-00
Lot numbers1/19, 10/18, 11/18, 12/17, 12/18, 2/19, 3/19, 6/18, 7/18, 8/18, 9/18, XI002A6, XI003A6, XI004G6, XI005G6, XI007H6, XI00816, XI00916, XI01016, XI01116, XI012J6, XI013J6, XI015K6, XI016L6, XI019A7, XI020B7, XI021B7, XI022C7, XI023C7, XI025D7, XL018A7

Product

Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL single-dose vials, Rx only, Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA 91730, NDC 0548-9021-00

Reason for recall

Crystallization: Particulate matter (Ketorolac Calcium Salt) was observed from several lots of retained samples.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1124-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.